Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1998
11/24/1998CA1340140C Human gamma, delta t cell antigen receptor polypetides and nucleic acids
11/23/1998CA2232810A1 Novel compounds
11/23/1998CA2232809A1 Novel compounds
11/23/1998CA2232808A1 Novel compounds
11/23/1998CA2232807A1 Novel compounds
11/23/1998CA2230996A1 Novel compounds
11/23/1998CA2221837A1 A novel human gene similar to a secreted protein frizb (atg-1639)
11/23/1998CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/22/1998CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9
11/21/1998CA2232811A1 Novel def1
11/21/1998CA2229436A1 A human gene similar to a secreted murine protein sdf5
11/21/1998CA2224473A1 A novel human gene similar to a secreted murine protein sdf5
11/20/1998CA2236613A1 Sample preparation for nucleic acid based diagnostic tests
11/19/1998WO1998052038A1 The use of a bone morphogenetic protein (bmp) receptor complex for screening
11/19/1998WO1998051825A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998WO1998051824A1 Reagents and methods useful for detecting disease of the urinary tract
11/19/1998WO1998051823A1 Electrophoretic analysis of molecules using immobilized probes
11/19/1998WO1998051821A1 Determination of cyclin-dependent kinase inhibitor p27 levels as a prognostic factor in cancer patients
11/19/1998WO1998051818A1 Method for treatment of deoxyribonucleic acid sequence by restrictase
11/19/1998WO1998051817A1 Molecular detection of chromosome aberrations
11/19/1998WO1998051810A1 Lentivirus-based gene transfer vectors
11/19/1998WO1998051809A1 Multigene vectors derived from hsv
11/19/1998WO1998051808A1 Methods for producing retroviral vectors with an altered tropism
11/19/1998WO1998051807A1 Episomal expression cassettes for gene therapy
11/19/1998WO1998051806A2 Recovery of transformed plants without selectable markers by nodal culture and enrichment of transgenic sectors
11/19/1998WO1998051805A1 Reagents and methods useful for detecting diseases of the prostate
11/19/1998WO1998051804A1 Polypeptides having aminopeptidase activity and nucleic acids encoding same
11/19/1998WO1998051803A1 Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
11/19/1998WO1998051802A1 Method for the stabilization of proteins and the thermostabilized alcohol dehydrogenases produced thereby
11/19/1998WO1998051801A1 Gene encoding for systemic acquired resistance in arabidopsis
11/19/1998WO1998051800A1 Plant gene constructs and their use
11/19/1998WO1998051799A1 Novel differentiation inhibitor
11/19/1998WO1998051798A1 Hgf polypeptides and their use in therapy
11/19/1998WO1998051797A1 Human vesicle binding protein
11/19/1998WO1998051796A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998WO1998051795A1 Double-stranded rna-binding protein
11/19/1998WO1998051794A1 Antimicrobial peptide
11/19/1998WO1998051793A1 Apo-2 RECEPTOR
11/19/1998WO1998051790A1 A novel nucleic acid molecule
11/19/1998WO1998051789A2 A METHOD TO CLONE mRNAs AND DISPLAY OF DIFFERENTIALLY EXPRESSED TRANSCRIPTS (DODET)
11/19/1998WO1998051788A2 Method and construct for inhibition of cell migration
11/19/1998WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
11/19/1998WO1998051783A1 DISCOVERY OF AND METHOD FOR CLONING AND PRODUCING THE PspGI RESTRICTION ENDONUCLEASE
11/19/1998WO1998051782A2 Human 3-hydroxyisobutyryl-coenzyme a hydrolase
11/19/1998WO1998051781A1 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background
11/19/1998WO1998051780A2 Method for increasing yields or recombinant proteins
11/19/1998WO1998051706A1 Tumor-associated antigen
11/19/1998WO1998051700A1 Retroviral envelopes having modified hypervariable polyproline regions
11/19/1998WO1998051699A1 Methods for production and purification of nucleic acid molecules
11/19/1998WO1998051697A2 Method for producing polymers having nucleo-bases as side-groups
11/19/1998WO1998051695A2 Novel polyketide derivatives and recombinant methods for making same
11/19/1998WO1998051693A1 Solid-phase nucleic acid isolation
11/19/1998WO1998051351A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
11/19/1998WO1998051336A1 Targeted delivery to t lymphocytes
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998WO1998051329A1 Cachexia remedy
11/19/1998WO1998051328A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
11/19/1998WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998WO1998051324A1 Peptide parathyroid hormone analogs
11/19/1998WO1998051321A1 Tissue factor for influencing blood vessel formation
11/19/1998WO1998051285A2 Cationic amphiphile formulations
11/19/1998WO1998051279A2 Method of making microencapsulated dna for vaccination and gene therapy
11/19/1998WO1998040483A3 28 human secreted proteins
11/19/1998WO1998037089A3 Matrix derived anti-hiv peptides and transdominant proteins
11/19/1998WO1998035061A3 Member of the tnf family useful for treatment and diagnosis of disease
11/19/1998WO1998035014A3 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
11/19/1998WO1998034640A3 Synthetic hiv gag genes
11/19/1998WO1998033929A3 Use of a polypeptide as cell receptor for adenoviruses
11/19/1998WO1998033896A3 Microorganisms with increased production of clavulanic acid
11/19/1998WO1998032843A3 Compositions and method for modulation of alkaloid biosynthesis and flower formation in plants
11/19/1998WO1998031810A3 Mammalian chemokines; receptors; reagents; uses
11/19/1998WO1998031802A3 Secreted proteins and polynucleotides encoding them
11/19/1998WO1998026062A3 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
11/19/1998WO1998026061A3 Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
11/19/1998WO1998026051A3 Tryparedoxin, expression plasmid, process of production, use, test system and pharmaceutical preparation
11/19/1998DE19721700C1 Mutierter OKT3-Antikörper Mutated OKT3 antibody
11/19/1998DE19720839A1 Baukastenprinzip-Technologie zur Herstellung von langen, exakten DNA-Konstrukten in vitro, insbesondere für die Herstellung von Konstrukten zur Erzeugung von künstlichen Chromosomen (MAC, mammalian artificial chromosome) aus zwei stabil klonierten DNA-Komponenten und der ditelomerische Vektor-Prototyp PTAT Modular system technology for the production of long, exact DNA constructs in vitro, in particular for the preparation of constructs for the production of artificial chromosomes (MAC, mammalian artificial chromosome) of two stable cloned DNA components and the prototype vector ditelomerische PTAT
11/19/1998CA2290781A1 Antimicrobial peptide
11/19/1998CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998CA2290755A1 The use of a bone morphogenetic protein (bmp) receptor complex for screening
11/19/1998CA2290628A1 Molecular detection of chromosome aberrations
11/19/1998CA2290477A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998CA2290443A1 Peptide parathyroid hormone analogs
11/19/1998CA2290074A1 Method for the stabilization of proteins and the thermostabilized alcohol dehydrogenases produced thereby
11/19/1998CA2290071A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998CA2290039A1 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background
11/19/1998CA2289953A1 Methods for producing retroviral vectors with an altered tropism
11/19/1998CA2289925A1 Electrophoretic analysis of molecules using immobilized probes
11/19/1998CA2289910A1 Therapeutic agent for cachexia
11/19/1998CA2289751A1 Gene encoding for systemic acquired resistance in arabidopsis
11/19/1998CA2289720A1 Hgf polypeptides and their use in therapy
11/19/1998CA2289117A1 Method and construct for inhibition of cell migration
11/19/1998CA2288641A1 Plant gene constructs and their use
11/19/1998CA2288599A1 Tumor-associated antigen
11/19/1998CA2288456A1 Method for increasing yields or recombinant proteins
11/19/1998CA2288328A1 Lentivirus-based gene transfer vectors
11/19/1998CA2288218A1 Novel differentiation-inhibitor
11/19/1998CA2288117A1 Tissue factor for influencing blood vessel formation
11/19/1998CA2287911A1 Apo-2 receptor
1 ... 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 3482 3483 3484 3485 3486 ... 4023